Pub fees email yes from A Phase I Study of the CDK4/6 Inhibitor Ribociclib (LEE011) in Pediatric Patients with Malignant Rhabdoid Tumors, Neuroblastoma, and Other Solid Tumors
Year: 2023
Type: other
Abstract: Pub fees email yes
Authors: Birgit Geoerger, Franck Bourdeaut, Steven G. DuBois, Matthias Fischer, James I. Geller, Nicholas G. Gottardo, Aurélien Marabelle, Andrew D.J. Pearson, Shakeel Modak, Thomas Cash, Giles W. Robinson, Marlyane Motta, Alessandro Matano, Suraj G. Bhansali, Jason R. Dobson, Sudha Parasuraman, Susan N. Chi
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361889616